Protocol Ledger | Public ClinicalTrials.gov v2 & FDA Drugs@FDA Clinical Research Directory

Which hospitals near you run major clinical trials, and how often do studies finish?

Protocol Ledger reconciles 54,890 interventional Phase II and Phase III clinical trial studies (2018 to 2026) across 22,436 canonical hospital research sites (10,046 California studies) and 4,879 consolidated biopharma, academic, and federal sponsors paired with 1,184 FDA Drugs@FDA original NDA and BLA approvals.

Public Clinical Trial Directory Summary (Publication 47c4426df7e9d67d5bfe)

  • Study status overview: 24,052 active protocols (13,787 recruiting now), 15,690 completed, and 6,796 early-stopped studies (12.38% overall; 30.22% of closed studies)
  • Reported WhyStopped causes: 1,629 slow-accrual stops (23.97% of stopped) compared with 735 safety stops and 416 futility stops
  • Hospital campus & sponsor lineage resolution: 793,923 disclosed hospital slots (83.66%) canonicalized via 49,607 campus merges, 155,062 anonymized CRO slots isolated, and 3,327 subsidiary protocols unified across 37 M&A parent groups

Empirical Clinical Trial Completion & Pipeline Research

Browse the Hospital & Sponsor Directory, inspect the 3D Clinical Site Map, compare organizations in Side-by-Side Comparison, explore all clinical trial research studies, review our reconciliation methodology, or configure privacy and browser analytics controls.